Instructions to Authors  by unknown
The Journal of Orthopaedics, Trauma and Rehabilitation (JOTR) aims 
to publish high-quality scientific papers that contribute to ortho-
paedics, trauma, orthopaedic rehabilitation and related knowl-
edge from all countries. Review articles, original articles, case 
reports and letters to the editor are accepted. The journal is pub-
lished twice a year by Elsevier.
The Editorial Board requires authors to be in compliance with 
the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals (URMs), which are compiled by the International 
Committee of Medical Journal Editors (ICMJE); current URMs are 
available at www.icmje.org.
These Instructions to Authors are revised periodically by the 
Editors as needed. Authors should consult a recent issue of the 
Journal or visit www.e-jotr.com for the latest version of these 
instructions. Authors are requested to ensure that submissions 
adhere exactly to the stated instructions and format. Recent 
issues of the Journal should be consulted for specific examples. 
Any manuscript not prepared according to these instructions will 
be returned immediately to the author(s) without review.
1. Manuscript Submission
1.1. Online Submission
Manuscripts (meaning all submission items, including all text, 
tables, artwork, cover letter, conflicts of interest disclosures, 
and any other required documents/material) must be submitted 
online to the JOTR through the Elsevier Editorial System (EES) at 
http://ees.elsevier.com/jotr. This site will guide authors stepwise 
through the submission process. If assistance is required, please 
refer to the tutorials for authors and/or customer support that are 
available on the EES website; you may also contact the Editorial 
Office. Please do not post, fax or e-mail your manuscripts to the 
Editorial Office.
Editorial Office
Journal of Orthopaedics, Trauma and Rehabilitation (JOTR)
c/o The Hong Kong College of Orthopaedic Surgeons
Room 905, 9th Floor
Hong Kong Academy of Medicine Jockey Club Building
99 Wong Chuk Hang Road, Aberdeen
Hong Kong SAR, China
Tel: (852) 2871-8722
Fax: (852) 2873-4077
E-mail: jotr@ejotr.org or hkcos@hkcos.org.hk
Official websites: www.e-jotr.com and www.ejotr.org
1.2. Important Information
•  Articles should be in Microsoft Word document format and pre-
pared in the simplest form possible. We will add in the correct 
font, font size, margins and so on according to the Journal’s style.
•  You may use automatic page numbering, but do NOT use other 
kinds of automatic formatting such as footnotes, headers and 
footers.
•  Put text, references, table headings and tables, and figure leg-
ends in one file.
•  Figures must be submitted as separate picture files, at the cor-
rect resolution and named according to the figure number and 
format, e.g., “Fig1.tif”, “Fig2.jpg”. Please see section 8.8. for more 
information.
1.3. Supporting Documents
The following documents must be included in your submission (refer 
also to the Checklist that follows these author instructions). Items (1) 
and (2) are mandatory. Items (3), (4) and (5) are required only if they 
are applicable to your manuscript.
(1) Cover Letter. This must include the following information: 
•  title of the manuscript 
•  corresponding author details (name, e-mail, mailing address, 
telephone and fax numbers) 
•  a statement that the material contained in the manuscript has 
not been previously published and is not being concurrently 
submitted elsewhere 
•  persons who do not fulfill the requirements to be listed as 
authors but who nevertheless contributed to the manuscript 
(such as those who provided writing assistance, for example) 
should be disclosed 
•  list of manuscripts that have been published, submitted, or 
are in press that are similar to the submission to the JOTR (and 
include in your submission copies of those similar manuscripts 
so that JOTR Editors can be assured there is no overlap) 
•  the signature of the corresponding author 
•  Optional: if you have a list of reviewers who you wish to review 
or not to review your manuscript, you may include this list in 
the cover letter 
(2) Authorship, Conflicts of Interest, Copyright Transfer and 
Ethics Statement. 
•  Each author’s contribution to the manuscript should be con-
firmed. 
•  Any and all potential and actual conflicts of interest should be 
listed (see Section 2 for more information). 
•  In the event that your manuscript is accepted for publication 
in the JOTR, you are required to transfer all copyright owner-
ship in and relating to the work to the Hong Kong Orthopaedic 
Association and the Hong Kong College of Orthopaedic 
Surgeons. 
•  Authors are required to certify that subjects’/patients’ rights and 
confidentiality have been well protected in all aspects and they 
consented to the study described in the manuscript, and that all 
relevant ethical safeguards have been met in relation to subject/
patient protection or animal experimentation. 
Please use the JOTR Authorship, Conflicts of Interest, Copyright 
Transfer and Ethics Statement form that follows these author 
instructions and that is also provided on the Journal’s website at 
www.e-jotr.com. Your signature and those of ALL your coauthors 
must be included.
(3) Ethics Committee Approval. Articles covering the use of 
human or animal samples in research, or human or animal 
experiments must be accompanied by a letter of approval from 
the relevant review committee or authorities. See Section 3 for 
more information.
(4) Signed Statement of Informed Consent. Articles where 
human subjects can be identified in descriptions, photographs 
or pedigrees in the manuscript must be accompanied by a 
signed statement of informed consent to publish (in print and 
online) the descriptions, photographs and pedigrees from each 
subject who can be identified. See Section 4 for more infor-
mation. You may use the JOTR Consent Form for Publication of 
Photographs/Information of Identifiable Patients that is provided 
on the Journal’s website at www.e-jotr.com if you do not have 
your own.
(5) Copyright Permission. If you have reproduced or adapted 
material from other copyrighted sources, the letter(s) of per-
mission from the copyright holder(s) to reproduce or adapt the 
copyrighted sources must be supplied. Otherwise, such material 
must be removed from your manuscript.
2. Disclosure of Conflicts of Interest
A conflict of interest occurs when an individual’s objectivity is 
potentially compromised by a desire for financial gain, promi-
nence, professional advancement or a successful outcome. JOTR 
Editors strive to ensure that what is published in the Journal 
is as balanced, objective and evidence-based as possible. 
Since it can be difficult to distinguish between an actual con-
flict of interest and a perceived conflict of interest, the Journal 
requires authors to disclose all and any potential conflicts of 
interest (more information is available at www.icmje.org/
ethical_4conflicts.html).
INSTRUCTIONS TO AUTHORS
Conflicts of interest may be financial or non-financial. Financial 
conflicts include financial relationships such as honoraria; 
educational grants; participation in speakers’ bureaus; member-
ship, employment, consultancies, stock ownership, or other equity 
interest; expert testimony or patent-licensing arrangements. Non-
financial conflicts include personal or professional relationships, 
affiliations, academic competition, intellectual passion, knowledge 
or beliefs that might affect objectivity.
Please ensure that all authors with any conflicts of interest 
are listed and the details of the conflict(s) described in the space 
provided on Page 1 of the JOTR Authorship, Conflicts of Interest, 
Copyright Transfer and Ethics Statement form.
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropri-
ate institutional review board or ethics committee approval 
is required, and such approval should be stated in the methods 
section of the manuscript. For those investigators who do not 
have formal ethics review committees, the principles outlined in 
the Declaration of Helsinki should be followed (World Medical 
Association. Declaration of Helsinki: ethical principles for medical 
research involving human subjects. Available at www.wma.net/
en/30publications/10policies/b3/17c.pdf).
For investigation of human subjects, state explicitly in the 
methods section of the manuscript that informed consent was 
obtained from all participating adult subjects and from parents or 
legal guardians for minors or incapacitated adults, together with 
the manner in which informed consent was obtained (e.g., oral or 
written).
For work involving animals, proper guidelines for their care and 
use should be observed. For those investigators who do not have 
formal institutional guidelines relating to animal experiments, 
the European Commission Directive 86/609/EEC for animal experi-
ments (available at http://ec.europa.eu/environment/chemicals/
lab_animals/legislation_en.htm) should be followed.
4. Identification of Patients in Descriptions, Photographs and 
Pedigrees
A signed statement of informed consent to publish (in print 
and online) patient descriptions, photographs and pedigrees 
should be obtained from all persons (parents or legal guardians 
for minors) who can be identified (including by the patients 
themselves) in such written descriptions, photographs or pedi-
grees. You may use the JOTR Consent Form for Publication of 
Photographs/Information of Identifiable Patients that is provided 
on the Journal’s website at www.e-jotr.com if you do not have 
your own. Such persons should be shown the manuscript before 
its submission. Omitting data or making data less specific to de-
identify patients is acceptable, but changing any such data is not 
acceptable.
5. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understanding 
that they have not been published previously in print or elec-
tronic format (except in abstract or poster form) and are not 
under consideration in totality or in part by another publication 
or electronic medium.
6. Basic Criteria
Articles should be written in English, using British English spell-
ing, and meet the following basic criteria: the material is original, 
the information is important, the writing is clear and concise, the 
study methods are appropriate, the data are valid, and the conclu-
sions are reasonable and supported by the data.
7. Article Categories
The categories of articles that are published in the Journal are 
listed and described below. Please select the category that best 
describes your paper. If your paper does not fall into any of these 
categories, please contact the Editorial Office.
7.1. Review Articles
These should aim to provide the reader with a balanced overview 
of an important and topical issue in research or clinical practice. 
They should cover aspects of a topic in which scientific consen-
sus exists as well as aspects that remain controversial and are the 
subject of ongoing scientific research. All articles and data sources 
reviewed should include information about the specific type of 
study or analysis, population, intervention, exposure, and tests or 
outcomes. All articles or data sources should be selected system-
atically for inclusion in the review and critically evaluated.
The maximum length is 4000 words, and the number of refer-
ences should not exceed 50. The format for review articles will be 
jointly decided by the Editors and the contributing author(s).
7.2. Original Articles
These articles typically include randomized trials, intervention 
studies,
 
studies of screening and diagnostic tests, laboratory and 
animal studies, cohort studies, cost-effectiveness
 
analyses, case-
control studies, and surveys with high response
 
rates, which rep-
resent new and significant contributions to the field.
Section headings should be: Abstract, Keywords, Introduction, 
Methods, Results, Discussion, Conflicts of Interest Statement (if 
any), Acknowledgements (if any), and References.
The Introduction should provide a brief background to the sub-
ject of the paper, explain the importance of the study, and state a 
precise study question or purpose.
The Keywords should include not more than 5 important words 
that would facilitate Internet searching for the article.
The Methods section should describe the study design and 
methods (including the study setting
 
and dates, patients/par-
ticipants with inclusion and exclusion
 
criteria, patient samples 
or animal specimens used, the essential features of any interven-
tions, the main outcome measures, the laboratory methods fol-
lowed, or data sources and how these were selected for the
 
study), 
and state the statistical procedures employed in the research.
The Results section should comprise the study results presented 
in a logical sequence, supplemented by tables and/or figures. Take 
care that the text does not repeat data that are presented in tables 
and/or figures. Only emphasize and summarize the essential fea-
tures of the main results.
The Discussion section should be used to emphasize the new 
and important aspects of the study, placing the results in context 
with published literature, the implications of the findings, and the 
conclusions that follow from the study results.
The maximum length is 3500 words, and the number of refer-
ences should not exceed 30.
7.3. Case Reports
These are short discussions of a case or case series with unique 
features not previously described that make an important teach-
ing point or scientific observation. They may describe novel 
techniques or use of equipment, or new information on diseases 
of importance. Section headings should be: Abstract, Keywords, 
Introduction, Case Report, Discussion, Conflicts of Interest 
Statement (if any), Acknowledgements (if any), and References.
The Introduction should describe the purpose of the present 
report, the significance of the disease and its specificity, and 
briefly review the relevant literature.
The Case Report should include statements of the problem, 
patient history, diagnosis, treatment, outcome and any other 
information pertinent to the case(s).
The Discussion should compare, analyze and discuss the simi-
larities and differences between the reported case and similar 
cases reported in other published articles. The importance or 
specificity of the case should be restated when discussing the dif-
ferential diagnoses. Suggest the prognosis of the disease and pos-
sibility of prevention.
The maximum length is 2000 words, and the number of refer-
ences should not exceed 10.
7.4. Letters to the Editor
Brief letters of constructive comments in response to previously 
published JOTR articles are welcome. These may also include 
interesting cases that do not meet the requirement of being truly 
exceptional, and other communications of general interest. Letters 
should have a title, be no longer than 500 words, may include 
1 table or figure and up to 10 references. Ensure that the corre-
sponding author’s mailing and e-mail addresses are included. 
Letters are edited, sometimes extensively, to sharpen their focus. 
They may be sent for peer review at the discretion of JOTR Editors. 
Letters are selected based on clarity, significance, and space.
8. Manuscript Preparation
Manuscripts should be prepared in Microsoft word (doc or docx) 
format. Text should be typed double-spaced on white A4 (297 × 
210 mm) paper, with outer margins of 2.5 cm. The manuscript 
should include a title page, abstract, keywords, text, conflicts of 
interest statement (if any), acknowledgements (if any), refer-
ences, and figures and tables as appropriate. Each section of the 
manuscript should begin on a new page. Pages should be num-
bered consecutively on the lower right-hand corner, beginning 
with the title page.
8.1. Title Page
The title page should contain the following information (in order, 
from the top to bottom of the page): 
• article category 
• article title
•  names (spelled out in full) of all authors*, and the institutions 
with which they are affiliated; indicate all affiliations with a 
superscripted lowercase letter after the author’s name and in 
front of the matching affiliation 
•  corresponding author details (name, e-mail, complete mailing 
address, telephone and fax numbers) 
• running title not exceeding 50 characters
*The name of each author should be written with the family name 
first, e.g., Cheung Yuen-Lam. There should normally not be more than 
6 authors per paper. Authorship is restricted only to direct partici-
pants who have contributed significantly to the work.
8.2. Abstracts and Keywords
An abstract of no longer than 150 words and up to 5 relevant key-
words (in alphabetical order) are required for the following article 
categories: Review Articles, Original Articles and Case Reports.
Abstracts for Original Articles should be structured into the fol-
lowing sections. Background/Purpose: briefly explain the impor-
tance of the study topic and state a precise study question or 
purpose. Methods: briefly introduce the methods used to perform 
the study; include information on the study design, setting, sub-
jects, interventions, outcome measures and analyses as appropri-
ate. Results: briefly present the significant results, with data and 
statistical details such as p values where appropriate; be sure 
that information in the abstract matches that in the main text. 
Conclusion: state the meaning of your findings, being careful to 
address the study question directly and to confine your conclu-
sions to aspects covered in the abstract; give equal emphasis to 
positive and negative findings.
Abstracts for Review Articles and Case Reports should be 
unstructured (in one single paragraph with no section head-
ings), and include information on the background/purpose of the 
report, methods, results (or case report), and conclusions.
A Chinese version of the article title and abstract should also 
be included. Translation service (from English to Chinese) will be 
provided only to non-Chinese authors.
Keywords should be taken from the Medical Subject Headings 
(MeSH) list of Index Medicus (www.nlm.nih.gov/mesh/mesh-
home.html).
No abstract and keywords are required for Letters to the Editor.
8.3. Main Text
The text for Original Articles should be organized into the fol-
lowing sections: Introduction, Methods, Results, Discussion, and 
References. Subheadings in long papers are acceptable if needed 
for clarification and ease of reading. Sections for Case Reports are: 
Introduction, Case Report, Discussion, and References. Each sec-
tion should begin on a new page.
8.3.1. Abbreviations
Where a term/definition will be continually referred to, it must 
be written in full when it first appears in the text, followed by the 
subsequent abbreviation in parentheses. Thereafter, the abbre-
viation may be used. An abbreviation should not be first defined 
in any section heading; if an abbreviation has previously been 
defined in the text, then the abbreviation may be used in a sub-
sequent section heading. Restrict the number of abbreviations to 
those that are absolutely necessary.
8.3.2. Numbers
Numbers that begin a sentence or those that are less than 10 
should be spelled out using letters. Centuries and decades should 
be spelled out, e.g., the Eighties or nineteenth century. Laboratory 
parameters, time, temperature, length, area, mass, and volume 
should be expressed using digits.
8.3.3. Units
Système International (SI) units must be used, with the exception 
of blood pressure values which are to be reported in mmHg. Use 
the metric system for the expression of length, area, mass, and 
volume. Temperatures are to be given in degrees Celsius.
8.3.4. Names of drugs, devices and other products
Use the Recommended International Non-proprietary Name 
(rINN) for medicinal substances, unless the specific trade name of 
a drug is directly relevant to the discussion. Generic drug names 
should appear in lowercase letters in the text. If a specific pro-
prietary drug needs to be identified, the brand name may appear 
only once in the manuscript in parentheses following the generic 
name the first time the drug is mentioned in the text.
When proprietary (brand) names of drugs, implants and instru-
ments, etc. are necessary, complete manufacturing details includ-
ing the name of the company, city, state and country should be 
provided the first time the product is mentioned in the text, for 
example, “…SPSS version 11 was used (SPSS Inc., Chicago, IL, 
USA)”. Thereafter, the generic term (if appropriate) should be used.
8.3.5. Gene nomenclature
Current standard international nomenclature for genes should be 
adhered to. For human genes, use genetic notation and symbols 
approved by the HUGO Gene Nomenclature Committee (http://
www.genenames.org). You may also refer to the resources avail-
able on PubMed at http://www.ncbi.nlm.nih.gov/guide/genes-
expression. The Human Genome Variation Society has a useful 
site that provides guidance in naming mutations at http://www.
hgvs.org/mutnomen/index.html. In your manuscript, genes 
should be typed in italic font and include the accession number.
8.3.6. Statistical requirements
Statistical analysis is essential for all research papers. Use correct 
nomenclature for statistical methods (e.g., two sample t test, not 
unpaired t test). Descriptive statistics should follow the scales 
used in data description. Inferential statistics are important for 
interpreting results and should be described in detail.
All p values should be presented to the third decimal place 
for accuracy. The smallest p value that should be expressed is p 
< 0.001 since additional zeros do not convey useful information; 
the largest p value that should be expressed is p > 0.99.
8.3.7. Personal communications and unpublished data
These sources cannot be included in the references list but may 
be described in the text. The author(s) must give the full name 
and highest academic degree of the person, the date of the com-
munication, and indicate whether it was in oral or written (let-
ter, fax, e-mail) form. A signed statement of permission should be 
included from each person identified as a source of information 
in a personal communication or as a source for unpublished data.
8.4. Conflicts of Interest Statement and/or Funding/Support 
Statement
Since it is difficult to distinguish between an actual conflict of 
interest and a perceived conflict of interest, the JOTR requires 
authors to disclose all and any potential conflicts of interest and 
let readers judge for themselves. Therefore, please ensure that 
you provide information about any potential financial and non-
financial conflicts of interest (see Section 2 for more information) 
in a concise paragraph after the main text.
All financial and material support for the research, work, writ-
ing and editorial assistance from internal or external agencies, 
including commercial companies, should be clearly and com-
pletely identified in a Funding/Support Statement.
8.5. Acknowledgements
After the Conflicts of Interest Statement and/or Funding/Support 
Statement, general acknowledgements for consultations and sta-
tistical analyses should be listed concisely, including the names 
of the individuals who were directly involved. Consent should be 
obtained from those individuals before their names are listed in 
this section. Those acknowledged should not include secretarial, 
clerical or technical staff whose participation was limited to the 
performance of their normal duties.
8.6. References
Authors are responsible for the accuracy and completeness of 
their references and for correct in-text citation.
8.6.1. In the main text, tables and figure legends
•  References should be identified using superscripted numbers, 
numbered consecutively in order of appearance in the text, and 
placed after punctuation. [The actual authors can be referred to, 
but the reference number(s) must always be given.]
•  References cited in tables or figure legends should be included 
in sequence at the point where the table or figure is first men-
tioned in the main text.
•  Do not cite abstracts unless they are the only available reference 
to an important concept.
•  Do not cite uncompleted work or work that has not yet been 
accepted for publication (i.e., “unpublished observation”, “per-
sonal communication”) as references. Also see Section 8.3.7.
8.6.2. In the references list
•  References should be compiled at the end of the manuscript 
according to the order of citation in the text.
•  References should be limited to those cited in the text only.
•  Journal references should include, in order, authors’ surnames 
and initials, article title, abbreviated journal name, year, volume 
and inclusive page numbers.
•  The surnames and initials of all the authors up to 3 should be 
included, but when authors number 4 or more, list the first 3 
authors only followed by “et al”.
•  Abbreviations for journal names should conform to those 
used in MEDLINE.
•  If citing a website, provide the author information, article title, 
website address and the date you accessed the information.
•  Reference to an article that is in press must state the journal 
name and, if possible, the year and volume.
Examples of the most common reference types are provided 
below. (Please pay particular attention to the formatting, word 
capitalization, spacing and style.)
Standard journal articles
Van Houwelingen AP, Garbuz DS, Masri BA, et al. Methicillin-
resistant infection after hip and knee replacement: reason to 
change practice? J Orthop Trauma Rehabil 2012;16:9–12.
Tong CK, Ho YF. Use of minimally invasive distal metatarsal oste-
otomy for correction of hallux valgus. J Orthop Trauma Rehabil 
2012;16:16–21.
Journal supplement
Kaplan NM. The endothelium as prognostic factor and therapeu-
tic target: what criteria should we apply? J Cardiovasc Pharmacol 
1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract
Hofele C, Schwager-Schmitt M, Volkmann M. Prognostic value 
of antibodies against p53 in patients with oral squamous 
cell carcinoma—five years survival rate. Laryngorhinootologie 
2002;81:342–5. [In German, English abstract]
Book with edition
Bradley EL. Medical and surgical management. 2nd ed. Philadelphia: 
Saunders; 1982.
Book with editors
Letheridge S, Cannon CR, editors. Bilingual education: teaching 
English as a second language. New York: Praeger; 1980.
Book chapter in book with editor and edition
Greaves M, Culligan DJ. Blood and bone marrow. In: Underwood 
JCE, editor. General and systematic pathology. 4th ed. London: 
Churchill Livingstone; 2004, p. 615–72.
Book series with editors
Wilson JG, Fraser FC, editors. Handbook of teratology, vols. 1–4. 
New York: Plenum Press; 1977–1978.
Bulletin
World Health Organization. World health report 2002: reducing 
risk, promoting healthy life. Geneva, Switzerland: World Health 
Organization; 2002.
Electronic publications
Duchin JS. Can preparedness for biological terrorism save us 
from pertussis? Arch Pediatr Adolesc Med 2004;158(2). Available 
at http://archpedi.ama-assn.org/cgi/content/full/158/2/106. 
Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual impairment 
in the elderly. Cochrane Database Syst Rev 2002(2):CD001054. 
Doi:10.1002/14651858.CD1001054.
Item presented at a meeting but not yet published
Khuri FR, Lee JJ, Lippman SM. Isotretinoin effects on head and neck 
cancer recurrence and second primary tumors. In: Proceedings 
from the American Society of Clinical Oncology, May 31–June 3, 
2003; Chicago, IL, abstract 359.
Item presented at a meeting and published
Cionni RJ. Color perception in patients with UV- or bluelight-
filtering IOLs. In: Symposium on cataract, IOL, and refractive sur-
gery. San Diego, CA: American Society of Cataract and Refractive 
Surgery; 2004, abstract 337.
Thesis
Ayers AJ. Retention of resin restorations by means of enamel etching 
and by pins. MSD thesis, Indiana University, Indianapolis, 1971.
Website
Glueckauf RL, Whitton J, Baxter J. Videocounseling for families of 
rural teens with epilepsy—project update. Telehealth News 1998. 
Available at http://www.telehealth.net/subscribe/newslettr_4a.
html#1. Accessed November 15, 2008.
Company/manufacturer publication/pamphlet
Eastman Kodak Company, Eastman Organic Chemicals. Catalog no. 
49. Rochester, NY: Eastman Kodak; 1977, p. 2–3.
8.7. Tables
Tables should supplement, not duplicate, the text. They should have 
a concise table heading, be self-explanatory, and numbered consec-
utively in the order of their citation in the text.
Items requiring explanatory footnotes should be denoted using 
these superscripted symbols (in order of appearance): *, †, ‡, §, ||, 
¶, #, **, ††, ‡‡. The footnotes themselves should be arranged under 
the table in the same order. (Note that if you have more than 10 
footnotes, then use superscripted lowercase letters in alphabetical 
order, with the footnotes themselves arranged under the table in 
alphabetical order.) Asterisks (*, **) are used only to indicate the 
probability level of tests of significance.
Abbreviations used in the table must be defined and placed after 
the footnotes in alphabetical order.
If you include a block of data or table from another source, 




The number of figures should be restricted to the minimum neces-
sary to support the textual material. Figures should have an inform-
ative figure legend and be numbered in the order of their citation in 
the text. All symbols and abbreviations should be defined in the fig-
ure legend in alphabetical order. Items requiring explanatory foot-
notes should follow the same style as that for tables as described in 
Section 8.7.
Patient identification should be obscured. All lettering should be 
done professionally and should be in proportion to the drawing, 
graph or photograph. Photomicrographs must include an internal 
scale marker, and the legend should state the type of specimen, 
original magnification and stain.
Figures must be submitted as separate picture files, at the correct 
resolution (see Section 8.8.2.) and named according to the figure 
number and format, e.g., “Fig1.tif”, “Fig2.jpg”.
8.8.2. Formats
Regardless of the application used, when your electronic artwork 
is finalized, please “save as” or convert the images to one of the fol-
lowing formats (note the resolution requirements for line drawings, 
halftones, and line/halftone combinations given below):
•  EPS: vector drawings. Embed the font or save the text as 
“graphics”.
•  TIFF: colour or greyscale photographs (halftones)—use a 
minimum of 300 dpi.
•  TIFF: bitmapped line drawings—use a minimum of 1000 dpi.
•  TIFF: combination of bitmapped line/halftone (colour or grey-
scale)—use a minimum of 600 dpi.
•  DOC, XLS or PPT: if your electronic artwork is created in any of 
these Microsoft Office applications, please supply “as is”.
Please do not:
•  Supply files that do not meet the resolution requirements detailed 
above;
•  Supply files that are optimized for screen use (such as GIF, BMP, 
PICT, WPG) as the resolution is too low;
•  Submit graphics that are disproportionately large for the 
content.
A detailed guide on electronic artwork is available at http://www.else-
vier.com/artworkinstructions. Please note that the cost of colour illus-
trations will be charged to the author.
9. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be acknowledged 
within 2 weeks of submission, and authors will be provided with 
a manuscript reference number for future correspondence. If such 
an acknowledgement is not received in a reasonable period of time, 
the author should contact the Editorial Office.
Manuscripts are reviewed by the Editorial Office to ensure that 
the submission contains all parts. The submission will not be 
accepted if the author has not supplied all parts of the manuscript 
as outlined in this document.
Manuscripts are then forwarded to the Editors for an initial 
review to determine which articles will be considered for publica-
tion based on their scientific merit, readability, interest and suit-
ability for the Journal. Manuscripts with insufficient priority for 
publication are rejected promptly. Note that the rejection rate for 
case reports is higher than for other article categories due to the 
current situation of a large number of case reports being submitted.
Manuscripts that appear meritorious and appropriate for the 
Journal are reviewed by at least two expert consultants assigned 
by the Editors. The JOTR follows a double-blind peer review proc-
ess. Authors may submit a list in their cover letter of reviewers who 
they wish to review or not to review their manuscript. However, the 
actual peer reviewers invited will remain anonymous and may or 
may not be the reviewers suggested by the authors as the selection 
of reviewers is at the sole discretion of JOTR Editors. The editors and 
reviewers will not disclose any information about a manuscript or 
its review to anyone except the manuscript’s corresponding author. 
The Editor-in-Chief reserves the right to make the final decision 
regarding the acceptance or rejection of manuscripts.
The corresponding author will usually be notified within 4 
weeks of whether the submitted article is accepted for publication, 
rejected, or subject to revision before acceptance (however, do note 
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